ERBB2 and cholangiocarcinoma: Similarly, current data on HER2 directed therapy in gallbladder cancer (GBC) are contradictory and evidence of efficacy are limited to retrospective case reports or case series [59,60,61], while more recent earlier investigations with HER-2 directed therapy in unselected populations failed to show activity in advanced CCA [62,63].